secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2026-05-15T10:30:06+00:00
Accession:  0001193125-26-225174
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics doubles authorized common stock to 400M shares; adds written consent right
--------------------------------------------------------------------------------

- Authorized common stock increased from 200M to 400M shares via charter amendment filed May 11, 2026.
- Stockholders approved the stock increase and written consent right at May 8, 2026 annual meeting.
- Written consent charter amendment and amended bylaws filed May 12, enabling stockholder action by written consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526225174/0001193125-26-225174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312526225174/d157366d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-225174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer